Connect with us

Hi, what are you looking for?

AI Business

Naver Expands Medical AI Team, Targets $183.85B Healthcare Market by 2032

Naver expands its medical AI team to capitalize on the booming $183.85 billion healthcare market by 2032, enhancing its Kmed.ai model and recruitment drive.

Naver is expanding its medical artificial intelligence (AI) development team as part of a strategic move into healthcare, positioning the sector as a key driver for future growth. This initiative follows the unveiling of a medical AI model last year, coupled with a series of acquisitions and investments in healthcare companies, indicating a robust commitment to healthcare commercialization.

According to IT industry sources on October 5, Naver’s Applied AI group has been transferred from Naver Cloud to its parent company, Naver, through an organizational restructuring. This group has spearheaded Naver’s medical AI developments, including the launch of “Kmed.ai,” a medical large language model (LLM) introduced in November of the previous year. The unit will now operate under the Tech Business division, which is responsible for overseeing Naver’s healthcare operations. The company is also actively recruiting AI agent engineers and backend developers specializing in healthcare AI services.

This structural change and hiring initiative reflect Naver’s aggressive investment approach within the healthcare landscape. Global market research firm Straits Research projects that the worldwide healthcare AI market will expand from $19.67 billion in 2023 to $183.85 billion by 2032, driven by aging populations and advancements in AI technology. Naver aims to leverage medical AI as a growth engine, succeeding its traditional search and commerce businesses, by establishing direct CEO oversight for the Tech Business division in May of last year.

In the latter half of last year, Naver invested in several healthcare startups, including clinical trial data platform J&P Medi and body composition analysis firm InBody, while also acquiring cloud electronic medical records company Senacle in November. Kmed.ai, co-developed with Seoul National University Hospital, garnered attention after achieving an average score of 96.4 on the Korean Medical Licensing Examination last year, highlighting its potential in the medical field.

With the integration of its healthcare business division and research organization, Naver is expected to explore various business opportunities utilizing medical AI agents. Plans are underway to develop AI agents designed for medical professionals to aid in clinical decision-making and to summarize or search through medical documents. Additionally, there will be AI agents focused on general consumers and patients. The “Naver Healthcare” platform, launched in October of last year, may play a crucial role in this endeavor, currently offering features such as predicted diagnoses based on user symptoms and the ability to schedule hospital appointments.

A spokesperson for Naver commented on the restructuring, stating, “The Applied AI group applies AI technology to vertical businesses in the healthcare sector,” and noted that the transition from Naver Cloud to Naver was part of routine organizational adjustments.

Industry observers suggest that Naver is laying the groundwork to secure an early foothold in the medical AI market. An industry source remarked, “Naver is accelerating commercialization based on various data including body composition and clinical data,” adding that ensuring compliance with personal information protection laws and the Ministry of Food and Drug Safety guidelines will be essential during this process.

As Naver intensifies its focus on the healthcare AI segment, the company’s efforts could reshape the landscape of medical technology in South Korea and beyond, further blurring the lines between technology and healthcare services. The commitment to integrate AI into healthcare not only underscores the potential for enhanced medical services but also highlights the broader trend of tech companies increasingly venturing into healthcare solutions.

See also
Marcus Chen
Written By

At AIPressa, my work focuses on analyzing how artificial intelligence is redefining business strategies and traditional business models. I've covered everything from AI adoption in Fortune 500 companies to disruptive startups that are changing the rules of the game. My approach: understanding the real impact of AI on profitability, operational efficiency, and competitive advantage, beyond corporate hype. When I'm not writing about digital transformation, I'm probably analyzing financial reports or studying AI implementation cases that truly moved the needle in business.

You May Also Like

AI Business

Red Hat advances enterprise AI with Small Language Models that achieve over 98% validity in structured tasks, prioritizing reliability and data sovereignty.

AI Research

OpenAI's o1 model achieves 81.6% diagnostic accuracy in emergency situations, surpassing human doctors and signaling a major shift in medical practice.

AI Regulation

Korea Venture Investment Corp. unveils AI-driven fund management systems by integrating Nvidia H200 GPUs to enhance efficiency and support unicorn growth.

AI Technology

Apple raises Mac mini starting price to $799 amid AI-driven inventory shortages, eliminating the $599 model in response to surging demand for advanced computing.

AI Research

IBM launches a Chicago Quantum Hub to create 750 AI jobs and expands its MIT partnership to advance quantum computing and AI integration.

AI Government

71% of Australian employees use generative AI daily, but only 36% trust its implementation, highlighting urgent calls for better policy frameworks and safeguards.

AI Regulation

The Academy of Motion Picture Arts and Sciences bars AI performances from Oscar eligibility, emphasizing human-authored content amid rising industry tensions over generative AI's...

AI Tools

Workday's stock jumps 3.73% to $126.96 amid AI product updates and earnings optimism, yet analysts cite a 49.8% undervaluation risk at $253.14.

© 2025 AIPressa · Part of Buzzora Media · All rights reserved. This website provides general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information presented. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult appropriate experts when needed. We are not responsible for any loss or inconvenience resulting from the use of information on this site. Some images used on this website are generated with artificial intelligence and are illustrative in nature. They may not accurately represent the products, people, or events described in the articles.